CORCEPT THERAPEUTICS INC (CORT)
US2183521028 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 366M 3.42% | 401.9M 9.81% | 482.375M 20.02% | 705.67M 46.29% | 826.28M 17.09% | 1.14B 37.97% | 1.351B 18.51% | 1.695B 25.46% | 1.826B 7.73% | 2.031B 11.23% | 2.642B 30.08% | |
| EBITDA YoY % growth | 125.6M -2.41% | 113.4M -9.71% | 108.324M -4.48% | 170.44M 57.34% | 189.72M 11.31% | 341.7M 80.11% | 352.61M 3.19% | 365.16M 3.56% | 413.41M 13.21% | 460.63M 11.42% | N/A | |
| EBIT YoY % growth | 124.5M -2.89% | 112.6M -9.56% | 107.282M -4.72% | 168.68M 57.23% | 242.7M 43.88% | 560.2M 130.82% | 747.62M 33.46% | 1.067B 42.72% | 1.187B 11.25% | 1.371B 15.50% | 1.627B 18.67% | |
| Operating Margin | 34.02% | 28.02% | 22.24% | 23.90% | 29.37% | 49.14% | 55.34% | 62.95% | 65.01% | 67.50% | 61.58% | |
| EPS YoY % growth | 0.89 4.71% | 0.88 -1.12% | 0.95 7.95% | 1.39 46.02% | 1.79 28.77% | 3.80 112.85% | 4.95 30.11% | 7.00 41.44% | 7.41 5.90% | 8.50 14.66% | 11.05 30.01% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.38 36.97% | 0.39 56.06% | 0.41 29.09% | 0.44 6.35% | 0.49 27.66% |
| Revenue Q2Q % growth | 201.98M 49.17% | 193.79M 32.00% | 199.44M 21.76% | 204.83M 12.21% | 212.39M 5.15% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 54.754M 72.89% | 52.159M 76.81% | 54.112M 52.03% | 56.488M 21.22% | 63.749M 16.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.41 46.43% | 0.29 | 0.12 | 42.54% |
| Q2 2024 Q2Q % growth | 0.32 28.00% | 0.23 | 0.09 | 36.40% |
| Q1 2024 Q2Q % growth | 0.25 78.57% | 0.22 | 0.03 | 11.41% |
| Q4 2023 Q2Q % growth | 0.28 100.00% | 0.26 | 0.02 | 6.40% |
| Q3 2023 Q2Q % growth | 0.28 -6.67% | 0.22 | 0.06 | 25.73% |
| Q2 2023 Q2Q % growth | 0.25 4.17% | 0.15 | 0.10 | 63.40% |
| Q1 2023 Q2Q % growth | 0.14 -30.00% | 0.20 | -0.06 | -29.00% |
| Q4 2022 Q2Q % growth | 0.14 -46.15% | 0.23 | -0.09 | -39.00% |
| Q3 2022 Q2Q % growth | 0.30 25.00% | 0.23 | 0.07 | 30.72% |
| Q2 2022 Q2Q % growth | 0.24 14.29% | 0.24 | 0.00 | 0.13% |
| Q1 2022 Q2Q % growth | 0.20 11.11% | 0.24 | -0.04 | -17.61% |
| Q4 2021 Q2Q % growth | 0.26 30.00% | 0.22 | 0.04 | 18.56% |
| Q3 2021 Q2Q % growth | 0.24 41.18% | 0.20 | 0.04 | 19.14% |
| Q2 2021 Q2Q % growth | 0.21 -8.70% | 0.16 | 0.05 | 30.72% |
| Q1 2021 Q2Q % growth | 0.18 -28.00% | 0.21 | -0.03 | -15.97% |
| Q4 2020 Q2Q % growth | 0.20 -16.67% | 0.19 | 0.01 | 5.04% |
| Q3 2020 Q2Q % growth | 0.17 -22.73% | 0.21 | -0.04 | -18.70% |
| Q2 2020 Q2Q % growth | 0.23 35.29% | 0.23 | 0.00 | 1.34% |
| Q1 2020 Q2Q % growth | 0.25 66.67% | 0.22 | 0.03 | 11.41% |
| Q4 2019 Q2Q % growth | 0.24 33.33% | 0.26 | -0.02 | -6.51% |
| Q3 2019 Q2Q % growth | 0.22 57.14% | 0.21 | 0.01 | 6.95% |
| Q2 2019 Q2Q % growth | 0.17 -15.00% | 0.18 | -0.01 | -7.41% |
| Q1 2019 Q2Q % growth | 0.15 -21.05% | 0.19 | -0.04 | -22.60% |
| Q4 2018 Q2Q % growth | 0.18 | 0.15 | 0.03 | 17.65% |
| Q3 2018 Q2Q % growth | 0.14 | 0.17 | -0.03 | -16.82% |
| Q2 2018 Q2Q % growth | 0.20 | 0.24 | -0.04 | -18.30% |
| Q1 2018 Q2Q % growth | 0.19 | 0.17 | 0.02 | 14.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 182.546M 47.69% | 175.41M | 7.136M | 4.07% |
| Q2 2024 Q2Q % growth | 163.796M 39.15% | 158.33M | 5.466M | 3.45% |
| Q1 2024 Q2Q % growth | 146.808M 38.95% | 144.03M | 2.778M | 1.93% |
| Q4 2023 Q2Q % growth | 135.405M 31.33% | 131.89M | 3.515M | 2.67% |
| Q3 2023 Q2Q % growth | 123.601M 21.53% | 122.07M | 1.531M | 1.25% |
| Q2 2023 Q2Q % growth | 117.715M 13.84% | 111.88M | 5.835M | 5.22% |
| Q1 2023 Q2Q % growth | 105.654M 12.76% | 106.97M | -1.316M | -1.23% |
| Q4 2022 Q2Q % growth | 103.1M 4.35% | 107.18M | -4.08M | -3.81% |
| Q3 2022 Q2Q % growth | 101.7M 5.83% | 109.74M | -8.04M | -7.33% |
| Q2 2022 Q2Q % growth | 103.4M 12.88% | 103.02M | 380K | 0.37% |
| Q1 2022 Q2Q % growth | 93.7M 18.01% | 100.86M | -7.16M | -7.10% |
| Q4 2021 Q2Q % growth | 98.8M 15.29% | 102.58M | -3.78M | -3.68% |
| Q3 2021 Q2Q % growth | 96.1M 11.36% | 99.133M | -3.033M | -3.06% |
| Q2 2021 Q2Q % growth | 91.6M 3.39% | 88.578M | 3.022M | 3.41% |
| Q1 2021 Q2Q % growth | 79.4M -14.81% | 93.643M | -14.243M | -15.21% |
| Q4 2020 Q2Q % growth | 85.7M -2.50% | 89.529M | -3.829M | -4.28% |
| Q3 2020 Q2Q % growth | 86.3M 5.89% | 92.69M | -6.39M | -6.89% |
| Q2 2020 Q2Q % growth | 88.6M 22.54% | 91.94M | -3.34M | -3.63% |
| Q1 2020 Q2Q % growth | 93.2M 43.83% | 88.746M | 4.454M | 5.02% |
| Q4 2019 Q2Q % growth | 87.9M 31.59% | 89.42M | -1.52M | -1.70% |
| Q3 2019 Q2Q % growth | 81.5M 26.55% | 79.563M | 1.937M | 2.43% |
| Q2 2019 Q2Q % growth | 72.3M 16.05% | 72.295M | 5K | 0.01% |
| Q1 2019 Q2Q % growth | 64.8M 12.31% | 70.678M | -5.878M | -8.32% |
| Q4 2018 Q2Q % growth | 66.8M | 70.998M | -4.198M | -5.91% |
| Q3 2018 Q2Q % growth | 64.4M | 68.762M | -4.362M | -6.34% |
| Q2 2018 Q2Q % growth | 62.3M | 69.865M | -7.565M | -10.83% |
| Q1 2018 Q2Q % growth | 57.7M | 59.346M | -1.646M | -2.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 17.5% | 0% | 22.74% |
| Revenue | 0% | 21.24% | 0% | 5.14% |